Date: 2011-07-25
Type of information: Fundraising
Company: CEVEC Pharmaceuticals (Germany)
Investors: NRW.BANK (Germany) - Creathor Venture Fonds (Germany) - a group of private and institutional investors - ERP Startfonds of KfW bank (Germany)
Amount: €6 million
Funding type: financing round
Planned used: The funding enables CEVEC to strengthen the growth of its protein and vaccine commercialization business of the proprietary CAP® Technology platform. CEVEC also intends to develop certain vaccines together with partners based on a further financing round, to be closed by the end of 2011.
Others: CEVEC Pharmaceuticals has closed a €6M financing round. NRW.BANK and Creathor Venture Fonds led this round which included the participation from current investors, a group of private and institutional investors and ERP Startfonds of KfW bank.
Therapeutic area: Technology - Services
